Osiris Therapeutics IncAdd to My Watchlist

OSIR:USNASDAQ GMIndustry: Therapeutics
  • 13.12
    Last
  • 0.06  0.46%
    Today's Change
  • 13.06
    Previous Close
  • Today
     
    11.80
    18.41
    52 Week Low - High
8:10 pm ET 11/21/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding34 million
Market Cap$450 million
Return on Equity ttm82.90%
Last DividendOSIR:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.059
EPS: Year Est. 12/14 ttm-0.017
 
EPS: Quarterly Actual 9/14 0.02
EPS: Quarterly Est. 12/14 0.00
 
Price/Earnings ttm223.66
Relative Price/Earnings12.228
Earnings Growth Rate76.47
Company Description
Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.
Revenue$24 million
Net Income$42 million
Total Assets$92 million
Employees70
Web Sitewww.Osiris.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!